Building a drug–target network and its applications
暂无分享,去创建一个
[1] M. DePamphilis,et al. HUMAN DISEASE , 1957, The Ulster Medical Journal.
[2] V. McKusick. Mendelian inheritance in man , 1971 .
[3] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[4] M. Kanehisa,et al. A heuristic graph comparison algorithm and its application to detect functionally related enzyme clusters. , 2000, Nucleic acids research.
[5] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[6] M. Vidal,et al. Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or "interologs". , 2001, Genome research.
[7] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[8] X. Chen,et al. TTD: Therapeutic Target Database , 2002, Nucleic Acids Res..
[9] A. Barabasi,et al. Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.
[10] R. Karp,et al. Conserved pathways within bacteria and yeast as revealed by global protein network alignment , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Lehár,et al. Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] Joshua M. Stuart,et al. A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules , 2003, Science.
[13] Yu Zong Chen,et al. Drug Adverse Reaction Target Database (DART) , 2003, Drug safety.
[14] Maria Jesus Martin,et al. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..
[15] John D. Westbrook,et al. TargetDB: a target registration database for structural genomics projects , 2004, Bioinform..
[16] Roded Sharan,et al. Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] P. Ball. Theatre: Playing dirty , 2004, Nature.
[18] B. Roth,et al. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.
[19] T. Hampton,et al. "Promiscuous" anticancer drugs that hit multiple targets may thwart resistance. , 2004, JAMA.
[20] Peter D. Karp,et al. MetaCyc: a multiorganism database of metabolic pathways and enzymes , 2005, Nucleic Acids Res..
[21] Richard Morphy,et al. From magic bullets to designed multiple ligands. , 2004, Drug discovery today.
[22] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[23] Michael Lässig,et al. Local graph alignment and motif search in biological networks. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Gerstein,et al. Annotation transfer between genomes: protein-protein interologs and protein-DNA regulogs. , 2004, Genome research.
[25] C. Wermuth,et al. Multitargeted drugs: the end of the "one-target-one-disease" philosophy? , 2004, Drug discovery today.
[26] Wojciech Szpankowski,et al. An efficient algorithm for detecting frequent subgraphs in biological networks , 2004, ISMB/ECCB.
[27] G. Church,et al. Modular epistasis in yeast metabolism , 2005, Nature Genetics.
[28] John D. Storey,et al. A network-based analysis of systemic inflammation in humans , 2005, Nature.
[29] B. Stockwell,et al. Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.
[30] Simon K. Mencher,et al. BMC Clinical Pharmacology BioMed Central Debate , 2005 .
[31] R. Karp,et al. From the Cover : Conserved patterns of protein interaction in multiple species , 2005 .
[32] U. Alon,et al. Spontaneous evolution of modularity and network motifs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] Péter Csermely,et al. The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.
[34] S. Frantz. Drug discovery: Playing dirty , 2005, Nature.
[35] R P Araujo,et al. A mathematical model of combination therapy using the EGFR signaling network. , 2005, Bio Systems.
[36] L. M. Espinoza-Fonseca,et al. The benefits of the multi-target approach in drug design and discovery. , 2006, Bioorganic & medicinal chemistry.
[37] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[38] John P. Overington,et al. Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.
[39] Sourav Bandyopadhyay,et al. Systematic identification of functional orthologs based on protein network comparison. , 2006, Genome research.
[40] R. Shoemaker. The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.
[41] T. Ideker,et al. Modeling cellular machinery through biological network comparison , 2006, Nature Biotechnology.
[42] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[43] R. Kishony,et al. Functional classification of drugs by properties of their pairwise interactions , 2006, Nature Genetics.
[44] P. Sorger,et al. Systems biology and combination therapy in the quest for clinical efficacy , 2006, Nature chemical biology.
[45] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[46] Mike Tyers,et al. BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..
[47] Chemical combination effects predict connectivity in biological systems , 2007, Molecular systems biology.
[48] Yi Wang,et al. DITOP: drug-induced toxicity related protein database , 2007, Bioinform..
[49] Jianwen Fang,et al. The reactive metabolite target protein database (TPDB) – a web-accessible resource , 2007, BMC Bioinformatics.
[50] Luhua Lai,et al. Prediction of potential drug targets based on simple sequence properties , 2007, BMC Bioinformatics.
[51] Xin Wen,et al. BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..
[52] M. Gerstein,et al. What is a gene, post-ENCODE? History and updated definition. , 2007, Genome research.
[53] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.
[54] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[55] Xiaomin Luo,et al. PDTD: a web-accessible protein database for drug target identification , 2008, BMC Bioinformatics.
[56] Helen E. Parkinson,et al. ArrayExpress—a public database of microarray experiments and gene expression profiles , 2006, Nucleic Acids Res..
[57] Benjamin A. Shoemaker,et al. Deciphering Protein–Protein Interactions. Part I. Experimental Techniques and Databases , 2007, PLoS Comput. Biol..
[58] J. Lehár,et al. Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.
[59] Jerzy Tiuryn,et al. Identification of functional modules from conserved ancestral protein-protein interactions , 2007, ISMB/ECCB.
[60] Humberto González Díaz,et al. Unified QSAR and network‐based computational chemistry approach to antimicrobials, part 1: Multispecies activity models for antifungals , 2008, J. Comput. Chem..
[61] Benjamin A. Shoemaker,et al. Deciphering Protein–Protein Interactions. Part II. Computational Methods to Predict Protein and Domain Interaction Partners , 2007, PLoS Comput. Biol..
[62] Yasubumi Sakakibara,et al. Statistical prediction of protein-chemical interactions based on chemical structure and mass spectrometry data , 2007, Bioinform..
[63] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[64] Martin Serrano,et al. Nucleic Acids Research Advance Access published October 18, 2007 ChemBank: a small-molecule screening and , 2007 .
[65] Mona Singh,et al. Organization of Physical Interactomes as Uncovered by Network Schemas , 2008, PLoS Comput. Biol..
[66] Robert B. Russell,et al. SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..
[67] Marcel J. T. Reinders,et al. Metabolic pathway alignment between species using a comprehensive and flexible similarity measure , 2008, BMC Systems Biology.
[68] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[69] John A. Tallarico,et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. , 2008, Nature chemical biology.
[70] P. Bork,et al. Large‐scale prediction of drug–target relationships , 2008, FEBS letters.
[71] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[72] Christian von Mering,et al. STITCH: interaction networks of chemicals and proteins , 2007, Nucleic Acids Res..
[73] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[74] Stefan Günther,et al. SuperPred: drug classification and target prediction , 2008, Nucleic Acids Res..
[75] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[76] Dongsup Kim,et al. Inference of Protein Complex Activities from Chemical-Genetic Profile and Its Applications: Predicting Drug-Target Pathways , 2008, PLoS Comput. Biol..
[77] Michael Schroeder,et al. Unraveling Protein Networks with Power Graph Analysis , 2008, PLoS Comput. Biol..
[78] Jean-Marc Schwartz,et al. A global view of drug-therapy interactions , 2007, BMC pharmacology.
[79] Hiroki Kobayashi,et al. Integrating Statistical Predictions and Experimental Verifications for Enhancing Protein-Chemical Interaction Predictions in Virtual Screening , 2009, PLoS Comput. Biol..
[80] Julie M. Sahalie,et al. An experimentally derived confidence score for binary protein-protein interactions , 2008, Nature Methods.
[81] Yanli Wang,et al. PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..
[82] Alessandra Carbone,et al. Joint Evolutionary Trees: A Large-Scale Method To Predict Protein Interfaces Based on Sequence Sampling , 2009, PLoS Comput. Biol..
[83] K. Chou,et al. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. , 2009, Bioorganic & medicinal chemistry.
[84] Philip E. Bourne,et al. Drug Discovery Using Chemical Systems Biology: Identification of the Protein-Ligand Binding Network To Explain the Side Effects of CETP Inhibitors , 2009, PLoS Comput. Biol..
[85] Eugenio Uriarte,et al. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors. , 2009, Molecular pharmaceutics.
[86] Alan F. Scott,et al. McKusick's Online Mendelian Inheritance in Man (OMIM®) , 2008, Nucleic Acids Res..
[87] Xin Guo,et al. Domain-oriented edge-based alignment of protein interaction networks , 2009, Bioinform..
[88] Keunwan Park,et al. Predicting the multi-modal binding propensity of small molecules: towards an understanding of drug promiscuity. , 2009, Molecular bioSystems.
[89] Jordi Mestres,et al. A chemogenomic approach to drug discovery: focus on cardiovascular diseases. , 2009, Drug discovery today.